Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 3/20 | 0.33 |
| ▸ | MAOB | P27338 | 3/20 | 0.33 |
| ▸ | PTPRC | P08575 | 2/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LATS1 | O95835 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | VSIR | Q9H7M9 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL783009 | 0.83 | CA2 (0.41) | CA12CA2CA14MAOAMAOB | |
| SCHEMBL20614704 | 0.81 | EPHX2 (0.35) | CA12CA2CA14MAOAMAOB | |
| SCHEMBL3772506 | 0.79 | CA2 (0.37) | CA12CA2CA14MAOAMAOB | |
| SCHEMBL18955286 | 0.79 | — | — | |
| SCHEMBL6535041 | 0.79 | MAOA (0.44) | CA12CA2CA14MAOAMAOB | |
| Hydrochloric Acid SCHEMBL2018578 | 0.77 | TSHR (0.46) | MAOAMAOBTSHR | |
| SCHEMBL7433191 | 0.77 | CA12 (0.50) | CA12CA2CA14MAOAMAOB | |
| SCHEMBL9612246 | 0.77 | MAOA (0.43) | CA12CA2CA14MAOAMAOB | |
| SCHEMBL763067 | 0.77 | CA12 (0.38) | CA12CA2CA14MAOAMAOB | |
| SCHEMBL10356266 | 0.76 | DGAT1 (0.34) | CA12CA2CA14DGAT1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200181223-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-11 | — | — | US | disclosed |
| CN-102893207-B | Polyamic acid ester liquid crystal alignment agent, and liquid crystal alignment film using same | NISSAN CHEMICAL IND LTD | 2015-05-20 | — | — | CN | disclosed |
| CN-103003741-B | Liquid crystal aligning agent containing compound having thermally releasable group and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2015-05-13 | — | — | CN | disclosed |
| CN-102893209-B | Liquid crystal aligning agent containing polyamic acid ester and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2015-05-06 | — | — | CN | disclosed |
| CN-102893206-B | Liquid crystal alignment agent containing end-modified polyamic acid ester, and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2015-04-01 | — | — | CN | disclosed |
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| CN-103003741-A | Liquid crystal aligning agent containing compound having thermally releasable group and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2013-03-27 | — | — | CN | disclosed |
| CN-102893206-A | Liquid crystal alignment agent containing end-modified polyamic acid ester, and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2013-01-23 | — | — | CN | disclosed |
| CN-102893209-A | Liquid crystal aligning agent containing polyamic acid ester and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2013-01-23 | — | — | CN | disclosed |
| CN-102893207-A | Polyamic acid ester liquid crystal alignment agent, and liquid crystal alignment film using same | NISSAN CHEMICAL IND LTD | 2013-01-23 | — | — | CN | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| CN-101657436-A | macrocyclic ghrelin receptor modulators and methods of use thereof | TRANZYME PHARMA INC US | 2010-02-24 | — | — | CN | disclosed |
| EP-0132441-A1 | ANTIBACTERIAL PEPTIDES | UNIVERSITY PATENTS, INC. (US) | 1985-02-06 | — | — | EP | disclosed |
| WO-1984002905-A1 | ANTIBACTERIAL PEPTIDES | UNIVERSITY PATENTS INC (US) | 1984-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181223-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | CA12 453/4885CA2 1521/4885CA14 478/4885 |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | CA12 1392/4885CA2 1637/4885CA14 1563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.